Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures



Status:Recruiting
Conditions:Neurology, Epilepsy
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:Any
Updated:2/4/2013
Start Date:October 2010
Contact:Mitch Herndon
Phone:877-352-4505

Use our guide to learn which trials are right for you!

Open-Label Extension Study to Evaluate the Safety of USL255 as Adjunctive Therapy in Patients With Refractory Partial-Onset Seizures Who Had Participated in P09-004, a Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study


The purpose of this study is to examine the safety of USL255 as adjunctive therapy in
patients with refractory partial onset-seizures.


Inclusion Criteria:

- Have completed the maintenance period of the P09-004 study.

- Continue to be treated with a stable dose of 1 to a maximum of 3 approved concomitant
AEDs.
We found this trial at
11
sites
?
mi
from
Newark, NJ
Click here to add this to my saved trials
?
mi
from
Ashville, NC
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
?
mi
from
Louisville, KY
Click here to add this to my saved trials
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Santa Clara, CA
Click here to add this to my saved trials
?
mi
from
St. Joseph, MO
Click here to add this to my saved trials